Search

everythinglearnresearchcommunity

for

Search:↓

Reflectance confocal microscopy is a promising non-invasive tool for diagnosing alopecia areata incognita.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Cell adhesion molecules are important in the development of certain skin diseases.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Blocking interferon-gamma might help treat various autoimmune diseases.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Mogamulizumab can cause hair loss and skin rashes.

Merkel cell increase is specific to certain skin diseases, not general skin growth.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The skin of both rat strains showed similar lectin binding patterns.

Upadacitinib improved multiple immune-related conditions in one patient.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Trichoepithelioma and desmoplastic trichoepithelioma have distinct features that can be identified using reflectance confocal microscopy.

Acitretin helped improve hand mobility and skin condition in a patient.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

New cytokine-targeted therapies show promise for treating alopecia areata.

Candida antigen is an effective and promising treatment for alopecia areata.